Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ARG1 | P05089 | 1/20 | 0.58 |
| ▸ | ARG2 | P78540 | 1/20 | 0.58 |
| ▸ | NOS2 | P35228 | 3/20 | 0.57 |
| ▸ | GSR | P00390 | 1/20 | 0.52 |
| ▸ | NOS1 | P29475 | 2/20 | 0.51 |
| ▸ | NOS3 | P29474 | 1/20 | 0.51 |
| ▸ | BHMT | Q93088 | 5/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4017239 | 1.00 | ARG1 (0.58) | ARG1ARG2NOS2GSRNOS1 | |
| Aspartic Acid SCHEMBL7373778 | 0.88 | NOS2 (0.48) | ARG1ARG2NOS2GSRNOS1 | |
| SCHEMBL296784 | 0.87 | ARG1 (0.62) | ARG1ARG2NOS2GSRNOS1 | |
| SCHEMBL9821119 | 0.87 | ARG1 (0.62) | ARG1ARG2NOS2GSRNOS1 | |
| SCHEMBL110108 | 0.87 | ARG1 (0.62) | ARG1ARG2NOS2GSRNOS1 | |
| Bromide SCHEMBL5505430 | 0.85 | ARG1 (0.60) | ARG1ARG2NOS2GSRNOS1 | |
| Bromide SCHEMBL5505432 | 0.85 | ARG1 (0.60) | ARG1ARG2NOS2GSRNOS1 | |
| Hydrochloric Acid SCHEMBL17633808 | 0.85 | ARG1 (0.60) | ARG1ARG2NOS2GSRNOS1 | |
| Hydrochloric Acid SCHEMBL9815370 | 0.85 | ARG1 (0.60) | ARG1ARG2NOS2GSRNOS1 | |
| Hydrochloric Acid SCHEMBL8472319 | 0.85 | ARG1 (0.60) | ARG1ARG2NOS2GSRNOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2074137-A1 | COMPOUNDS AS APTAMER-DIMERS AND THEIR USES IN DIAGNOSIS AND THERAPY | Bayer Schering Pharma Aktiengesellschaft (DE) | 2009-07-01 | — | — | EP | disclosed |
| US-20080207523-A1 | COMPOUNDS AS APTAMER-DIMERS AND THEIR USES IN DIAGNOSIS AND THERAPY | BAYER SCHERING PHARMA AG (DE) | 2008-08-28 | — | — | US | disclosed |
| EP-1208116-B1 | SOMATOSTATIN ANALOGS, RADIOLABELLED DERIVATIVES THEREOF AND THEIR USE | XANTHUS PHARMACEUTICALS INC (US) | 2008-04-30 | — | — | EP | disclosed |
| US-7351398-B2 | Stabilization of radiopharmaceutical compositions using hydrophilic thioethers | CIS BIO INTERNATIONAL (FR) | 2008-04-01 | — | — | US | disclosed |
| US-7351397-B2 | Stabilization of radiopharmaceutical compositions using hydrophilic 6-hydroxy chromans | CIS BIO INTERNATIONAL (FR) | 2008-04-01 | — | — | US | disclosed |
| WO-2008028530-A1 | COMPOUNDS AS APTAMER-DIMERS AND THEIR USES IN DIAGNOSIS AND THERAPY | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-03-13 | — | — | WO | disclosed |
| EP-1897886-A1 | Compounds as aptamer-dimers and their uses in diagnosis and therapy | Bayer Schering Pharma Aktiengesellschaft (DE) | 2008-03-12 | — | — | EP | disclosed |
| EP-1808184-A2 | Stabilisation of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman | CIS bio international (FR) | 2007-07-18 | — | — | EP | disclosed |
| US-7238340-B1 | Monoamine, diamide, thiol-containing metal chelating agents | CIS BIO INTERNATIONAL (FR) | 2007-07-03 | — | — | US | disclosed |
| US-20070066516-A1 | Compounds comprising cyclized somatostatin receptor binding peptides | SCHERING AKTIENGESELLSCHAFT (DE) | 2007-03-22 | — | — | US | disclosed |
| CN-1158090-A | Metal chelating agent containing monoamine, hydrazine and thiol | DIATECH INC (US) | 1997-08-27 | — | — | CN | disclosed |
| EP-0775160-A1 | CYCLIC HEXAPEPTIDE SOMATOSTATIN ANALOGUES | DIATECH, INC. (US) | 1997-05-28 | — | — | EP | disclosed |
| US-5620675-A | MEDICAL DIAGNOSIS | DIATECH, INC. (US) | 1997-04-15 | — | — | US | disclosed |
| EP-0720621-A1 | RADIOLABELED SOMATOSTATIN-DERIVED PEPTIDES FOR IMAGING AND THERAPEUTIC USES | Diatide, Inc. (US) | 1996-07-10 | — | — | EP | disclosed |
| WO-1996004308-A1 | CYCLIC HEXAPEPTIDE SOMATOSTATIN ANALOGUES | DIATECH, INC. (US) | 1996-02-15 | — | — | WO | disclosed |
| WO-1995033497-A1 | MONOAMINE, DIAMIDE, THIOL-CONTAINING METAL CHELATING AGENTS | DIATECH, INC. (US) | 1995-12-14 | — | — | WO | disclosed |
| EP-0649434-A1 | RADIOACTIVELY-LABELED SOMATOSTATIN-DERIVED PEPTIDES FOR IMAGING AND THERAPEUTIC USES | Diatide, Inc. (US) | 1995-04-26 | — | — | EP | disclosed |
| WO-1995003330-A1 | SOMATOSTATIN DERIVATIVES AND THEIR RADIOLABELLED PRODUCTS | DIATECH, INC. (US) | 1995-02-02 | — | — | WO | disclosed |
| WO-1995000553-A1 | RADIOLABELED SOMATOSTATIN-DERIVED PEPTIDES FOR IMAGING AND THERAPEUTIC USES | DIATECH, INC. (US) | 1995-01-05 | — | — | WO | disclosed |
| WO-1994000489-A2 | RADIOACTIVELY-LABELED SOMATOSTANTIN-DERIVED PEPTIDES FOR IMAGING AND THERAPEUTIC USES | DIATECH, INC. (US) | 1994-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080207523-A1 | COMPOUNDS AS APTAMER-DIMERS AND THEIR USES IN DIAGNOSIS AND THERAPY | PCNA, ADAR, TYMP | ARG1 2195/4885ARG2 2396/4885NOS2 4178/4885 |
| US-20070066516-A1 | Compounds comprising cyclized somatostatin receptor binding peptides | SSTR5, SSTR4, SSTR3 | ARG1 1687/4885ARG2 2528/4885NOS2 3580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.